Laparoscopic stomach surgery with added heated fluid chemotherapy
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial compares standard laparoscopic surgery for stomach cancer versus the same surgery plus HIPEC, which is heated chemotherapy placed in the abdomen during the operation. It aims to see if adding the heated chemotherapy improves outcomes for people with higher-stage stomach cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newly diagnosed stomach cancer: you have not had chemotherapy, radiation, or other cancer treatment yet
- Age 18–80, and you are male or not pregnant (and not breastfeeding)
- Stomach cancer confirmed as gastric adenocarcinoma, and doctors plan laparoscopic (robot-assisted) radical surgery
- Cancer is T3 or higher with no spread to distant organs, and you’re thought to be eligible for laparoscopic D2 lymph node removal
- You are well enough for surgery: good blood counts, good liver/kidney tests, and good performance status (ECOG 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies whether adding a heated chemotherapy procedure during surgery (HIPEC) before the main cancer treatment can lower the chance that stomach cancer returns in the belly. It is for people with advanced stomach cancer who are at higher risk of cancer coming back in the peritoneum (the lining of the abdomen).
This trial combines heated chemotherapy directly into the abdomen (HIPEC) with standard chemotherapy and an immunotherapy drug to treat advanced stomach cancer that has spread to the lining of the abdomen. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial studies a combination treatment for stomach cancer that has spread to the lining of the abdomen. It uses a special way to deliver heated chemotherapy directly into the abdomen, along with an immunotherapy drug that helps your immune system attack the cancer.
This trial tests whether adding heated chemotherapy to the belly right after surgery can help people with stomach cancer live longer. It is done during the same operation, aiming to kill any remaining cancer cells.
This study tests whether a specialized surgery called HIPEC (heat-treated chemotherapy placed in the belly) can improve outcomes for people with advanced stomach cancer that has reached the lining of the abdomen. It’s given after you’ve already had standard chemotherapy, aiming to better control disease in the belly.
This study tries to better predict how well patients do after heated chemotherapy placed in the abdomen during surgery for stomach or colon cancer that has spread to the lining of the abdomen. It may help doctors choose the best treatment plan and timing for future patients.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.